Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SynCoRAS: Lovastatin and Lamotrigine in RAS Pathway Disorders
NCT03504501Phase 2Terminated
- Sponsor
- Technical University of Munich
- Start
- Mar 2019
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lovastatin, lamotrigine in cognitive impairment, sponsored by Technical University of Munich. Started Mar 2019; status: terminated.
02
Drugs
lovastatinlamotrigine
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT03504501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03504501.